Gene therapy in development for deadly newborn lung disease
A gene therapy in development by researchers at The Ottawa Hospital, CHEO and uOttawa in collaboration with the University of Guelph, is showing dramatic results in mice with this disorder, improving their life expectancy from two days to over six months, according to...
New funding for gene therapy development at Xplore Lab
Xplore Lab and their collaborators at the University of Guelph have received a Canadian Institutes of Health Research project grant and a Collaborative Health Research Project grant to further develop an AAV vector expressing human SPB to test its potential as a...
Moving forward with a phase 1 trial
Dr. Bernard Thébaud and colleagues have received a $638,000 grant from the Stem Cell Network with in-kind matching funds from MDTB Cells GmbH to conduct a phase I clinical trial of umbilical cord cell therapy for premature babies. This trial aims to determine if this...
Healing damaged lungs in premature babies
Dr. Bernard Thébaud and colleagues have been awarded $300,000 from the Ontario Institute for Regenerative Medicine (OIRM) to conduct research in preparation for a clinical trial of umbilical cord stem cell therapy for premature babies with BPD; the team hopes to...
